Please login to read the full article.
Scrip Regulatory Affairs
EU adopts a common definition for nanomaterials to provide regulatory clarity
21 October 2011
Vibha Sharma
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- US FDA's de novo proposal will not result in significant time saving, says medtech association
- Higher US generic drugs user fee for foreign units 'discriminatory, anti-competitive', say Indian firms
- France votes for more regulatory transparency, tighter safety monitoring and tougher promotion controls
- Some relief for pharma as French reform bill nears final approval
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
